Skip to main content

Bank of New York Mellon Corp

Bank

Position in RARE — Ultragenyx Pharmaceutical Inc.

CIK 1390777 NEW YORK, NY

Position in RARE

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$7,146,563
+$276,325 QoQ
Shares Held
341,125
+14.2% QoQ
Ownership
0.346%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 84.27555881275192.ToString("F0")% Shared 0.ToString("F0")% None 15.724441187248075.ToString("F0")%

Common Shares in RARE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Bank of New York Mellon Corp holds $4,202,987,460 across 269 Biotechnology names. RARE ranks #73 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RARE

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $7,146,563 341,125
2025-12-31 $6,870,238 298,706
2025-09-30 $9,771,333 324,845
2025-06-30 $17,230,524 473,887
2025-03-31 $25,207,981 696,161
2024-12-31 $31,088,588 738,973
2024-09-30 $42,889,315 772,085
2024-06-30 $32,137,851 781,943
2024-03-31 $42,565,212 911,656
2023-12-31 $48,337,884 1,010,830
2023-09-30 $22,163,813 621,706
2023-06-30 $29,660,937 642,986
2023-03-31 $26,133,566 651,710
2022-12-31 $30,195,293 651,744
2022-09-30 $30,465,744 735,710
2022-06-30 $47,371,945 794,032
2022-03-31 $54,830,416 755,032
2021-12-31 $71,438,065 849,543
2021-09-30 $77,955,272 864,345
2021-06-30 $81,987,361 859,857
2021-03-31 $93,583,237 821,915
2020-09-30 $63,482,648 772,389
2020-06-30 $59,067,750 755,149
2020-03-31 $31,297,201 704,416